VesselMetaKAN: vessel-guided meta-learned interpretable classification for diabetic retinopathy grading - Report - MDSpire

VesselMetaKAN: vessel-guided meta-learned interpretable classification for diabetic retinopathy grading

  • By

  • TianQi Yang

  • GuoYong Chen

  • Lu Liu

  • July 16, 2026

Share

Clinical Report: VesselMetaKAN Framework for Diabetic Retinopathy Classification

Overview

VesselMetaKAN is a two-stage framework designed for the interpretable classification of diabetic retinopathy (DR) using vessel guidance and meta-learning. It achieved significant performance metrics on the APTOS 2019 dataset.

Background

Diabetic retinopathy is a major cause of preventable blindness, affecting millions globally. Early detection through automated grading systems is essential for effective public health interventions. However, existing deep learning methods face challenges in accurately identifying vascular structures critical for DR diagnosis.

Data Highlights

MetricValue
Accuracy74.9 ± 0.4%
Macro-F158.7 ± 0.6%
QWK0.838 ± 0.005
Best Single Run Accuracy75.44%
Best Single Run Macro-F159.44%
Best Single Run QWK0.843

Key Findings

  • VesselMetaKAN integrates vessel guidance with meta-learning for DR classification.
  • Stage 1 utilizes GMF-SwinUnet for vessel segmentation with advanced techniques like Frangi-guided attention fusion.
  • Stage 2 employs KAN-MAML for interpretable decision-making and meta-learning.
  • Ablation studies confirmed the importance of vessel guidance and KAN-based interpretability.
  • VesselMetaKAN outperformed EfficientNet-B4 in key grading metrics with statistical significance (p < 0.05).

Clinical Implications

The VesselMetaKAN framework offers a robust and interpretable solution for diabetic retinopathy grading, addressing critical challenges in vessel segmentation and feature learning.

Conclusion

VesselMetaKAN represents a significant advancement in automated diabetic retinopathy classification, combining interpretability with high performance.

Related Resources & Content

  1. Frontiers in Medicine, 2026 -- AI-driven saliency-guided retinal vessel segmentation framework for sustainable digital pathology
  2. Frontiers in Medicine, 2026 -- Detection of Referable Diabetic Retinopathy using Machine Learning on Routine Clinical Data
  3. Frontiers in Endocrinology, 2026 -- Diagnostic accuracy and clinical performance of deep learning models for grading diabetic retinopathy: a systematic review and meta-analysis
  4. npj Digital Medicine -- Advanced Geometric-Topological Transfer Learning Techniques for Accurate Vessel Segmentation in Three-Dimensional Medical Imaging
  5. Diabetes Care, 2026 -- Children and Adolescents: Standards of Care in Diabetes
  6. PMC -- Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial
  7. International Journal of Retina and Vitreous -- The efficacy of artificial intelligence in diabetic retinopathy screening: a systematic review and meta-analysis
  8. 14. Children and Adolescents: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
  9. Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial - PMC
  10. The efficacy of artificial intelligence in diabetic retinopathy screening: a systematic review and meta-analysis | International Journal of Retina and Vitreous | Springer Nature Link

Original Source(s)

Related Content